Autolus Company
Autolus is in T-cell programming and manufacturing technology.
Investors
Technology:
CAR-T
Industry:
Healthcare
Headquarters:
London, England, United Kingdom
Founded Date:
2014-01-01
Employees Number:
101-250
Funding Status:
IPO
Investors Number:
13
Total Funding:
631700000
Estimated Revenue:
$50M to $100M
Last Funding Date:
2021-11-08
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership